Trials / Enrolling By Invitation
Enrolling By InvitationNCT06743620
Observational Registry for Iltamiocel Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence
Prospective Observational Long-Term Safety and Effectiveness Registry of Patients Who Have Received Iltamiocel as Part of Cook Myosite, Inc. Sponsored CELLEBRATE Clinical Study in Patients With Persistent or Recurrent Stress Urinary Incontinence (SUI) Following Surgical Treatment
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 96 (estimated)
- Sponsor
- Cook MyoSite · Industry
- Sex
- Female
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this registry is to collect observational, long-term safety and effectiveness data in subjects who have received at least one dose of iltamiocel as part of the CLBT clinical study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | iltamiocel | This is an observational study with no intervention. |
Timeline
- Start date
- 2025-04-11
- Primary completion
- 2032-04-01
- Completion
- 2032-04-01
- First posted
- 2024-12-20
- Last updated
- 2025-04-29
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06743620. Inclusion in this directory is not an endorsement.